Slingshot members are tracking this event:

Aimmune (AIMT) to File Investigational New Drug Application for Egg Allergy in 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Additional Information

Additional Relevant Details Update on 1/4/2018: Initially expected to file NDA for Egg Allergy in Late 2016, now it is expected in 2018.
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Egg Allergy, Investigational New Drug Application